-
We are pleased to announce the appointment of Nagihan ŞENGÜL KARPUZ to Board of Directors
VSY Biotechnology, leading ophthalmic and orthopedic medical device and biotechnology company, announces the appointment of Nagihan ŞENGÜL KARPUZ to the company’s Board of Directors. Nagihan Şengül Karpuz has been appointed Board Member of VSY Biotechnology. She began her carrier at E&Y and has spent most of her career at Yıldız Holding, working in various areas related to tax compliance, tax policies, IFRS reporting, financial consolidation, global insurance management, budget, accounting and financial performance reporting processes. She recently has founded NSK Strategic Consultancy Company after leaving her latest role as Vice President of Financial Affairs of of Yıldız Holding. Nagihan holds a degree in Economics from Middle East Technical University and …
-
Enova® is Available Now in C Haptic Model
VSY Biotechnology announces the launch of the Enova® C Haptic Model IOL. Enova® is the first and only 100% Glistening-Free, Dry-Packed hydrophobic acrylic IOL. Moreover, no warming or special conditioning is required before surgery! VSY Biotechnology Launches Enova® 100% Glistening-Free Hydrophobic Acrylic IOL in C Haptic Model. The unique composition of Enova® material allows uniform hydration of specific sites to have controlled water uptake and resistance to glistening formation. Glistening study was performed at the Intermountain Ocular Research Center (Mamalis/Werner Laboratory), John A. Moran Eye Center, University of Utah and the unique composition of Enova® hydrophobic acrylic IOL shows Zero Glistening and Zero Haze compared with other IOLs1. Enova® is packaged…
-
VSY Biotechnology Appoints Can Ongen to Board of Directors
VSY Biotechnology, leading ophthalmic and orthopedic medical device and biotechnology company, announces the appointment of seasoned executive leader Can Ongen to the company’s Board of Directors. In this role, Can Ongen will also lead VSY Biotechnology’s sales and marketing activities with a view to further strengthening the company’s position worldwide. Can brings over 25 years of global leadership experience in medical devices, surgical implants, capital equipment, consumer and pharmaceuticals, having served in senior executive global commercial and marketing roles for Alcon and Galderma. “We are delighted to welcome Can to our Board of Directors.” said Mr. Ercan Varlibas, Chairman of the Board of VSY Biotechnology. “Can is ideally suited to…
-
VSY Biotechnology GmbH, Signs Agreement with WAKAMOTO PHARMACEUTICAL CO., LTD. on Intraocular Lens Products
VSY Biotechnology GmbH, an innovation-driven company with its progressive R&D activities in ophthalmology, visco supplementation in orthopedy and medical esthetics, announced today an agreement with WAKAMOTO PHARMACEUTICAL CO., LTD. (hereinafter refer to "WAKAMOTO PHARMACEUTICAL") to provide new treatments for cataract surgeries in Japan. The agreement includes a licensing arrangement with WAKAMOTO PHARMACEUTICAL to develop and launch intraocular lenses (IOLs) in Japan. "We’re very excited to work with WAKAMOTO PHARMACEUTICAL with our IOLs we have developed to inspire surgeons to have smooth and successful surgeries and people who have cataract to see and live better" said Fatih Ergin, CEO, VSY Biotechnology. "This in-licensing of IOLs will be an entry into a…
-
Thanks to VSY Biotechnology, ophthalmologist will have more comfortable surgery experience and patients will have more enhanced vision
VSY Biotechnology provides the best vision to people worldwide and supplies the best technology to ophthalmologists. The company’s Pre-loaded IOL System Patent has been granted by the Japan Patent Office. VSY Biotechnology’s innovations are indeed for the comfort of everyone in the world. VSY Biotechnology GmbH, an innovation-driven company with its progressive R&D activities in ophthalmology, provides the new treatment possibilities and supply the best technology to ophthalmologists. VSY Biotechnology Patent protecting the Pre-loaded Intraocular Lens Injector systems’ innovative design has been granted by the Japan Patent Office (JPO). JPO has registered the patent called Ancillary for the Storage and the Injection of Intra Ocular Lens protecting Pre-loaded IOL injector…
-
„Supreme Harmony“ for OVD Needs
VSY Biotechnology Introduces Protectalon DUO Kit, demonstrating commitment to Ophthalmic Surgery! Eye Care Professionals meet their OVD needs at different stages of cataract surgery with a single kit. It is available now for safe, fast and smooth surgery! SPECIFICATIONS: Dual Pack containing one unit cohesive and one unit dispersive OVDs High Filling Volume (1.1 ml Cohesive + 1.1 ml Dispersive) VSY Biotechnology GmbH, an innovation-driven company with progressive R&D activities in ophthalmology, launches a new surgical experience with Protectalon Duo. Protectalon DUO, dual pack containing high filling volume of one unit Cohesive (14 mg/mL, 1.1 mL) and one unit Dispersive (30 mg/ml, 1.1 ml) NaHA based OVDs provides reliable anterior chamber…
-
VSY Biotechnology Announce the Winners of 2020 Ophthalmology Star Awards (OSA)
VSY Biotechnology GmbH, an innovation-driven company with progressive R&D activities in ophthalmology, has announced the winners of the 2020 Ophthalmology Star Awards. This year’s “Ophthalmology Star Award” is dedicated to Dr. Li Wenliang, an an ophthalmologist who was the first to raise the alarm about COVID-19. Ophthalmologists applied for the contest with their articles until September 18, 2020, from the OSA page. (https://www.vsybiotechnology.com/…) on the VSY Biotechnology website. Their articles must have been published in a scientific journal as of January 2019. The OSA team received applications from all around the world. Three ophthalmologists are awarded ranks based upon their scientific research’s usefulness for the clinical ophthalmologist, novelty, and readability…
-
Willkommen in Deutschland, VSYBiotechnology
VSY Biotechnology announced that it is moving its headquarters from the Netherlands to Germany. VSY Biotechnology GmbH will be the company’s new headquarters. VSY Biotechnology commenced operations in the late 90s. Since then, the company has achieved several milestones on the way to becoming a global player in the innovation-driven medical device sector. VSY Biotechnology’s General Manager, Dr. Fatih Ergin emphasizes the company’s passion for innovation and continuously improving standards in all areas; these traits have enabled VSY Biotechnology to garner several innovation awards, international patents, and millions of happy patients together with thousands of satisfied healthcare practitioners. Dr. Ergin also highlights the company’s performance during the COVID19 crisis,…
-
Countdown to the Ophthalmology Star Awards
As part of the Ophthalmology Star Awards (OSA), articles by ophthalmologists published in English since January 2019 are being evaluated by an international jury. Ophthalmologists can apply for the contest until July 15, 2020, from the OSA page (https://www.vsybiotechnology.com/…) on the VSY Biotechnology website. The names of the finalists will be announced at the VSY Biotechnology Satellite Symposium during the ESCRS 2020 Congress. Ophthalmology Star Awards will be held in memory of Chinese ophthalmologist Dr. Li Wenliang and in the name of all healthcare professionals fighting fearlessly against coronavirus. Dr. Wenliang realized the potential for a new virus outbreak in the hospital where he worked in the Wuhan District of…
